Disc Medicine Drug Meets Main and Secondary Goals in Late-Stage Trial
Disc Medicine said its experimental pill for a rare disease causing extreme pain from sunlight met all main and secondary goals in a late-stage trial. Shares surged 65% in premarket trading.